Epicentre® (an Illumina company) founded in 1987, uses its expertise in enzyme manufacturing to produce innovative kits for life science research. The kits and reagents manufactured by Epicentre contribute to breakthrough studies in genomics and transcriptomics. Products are available for DNA and RNA sequencing, gene expression analysis, DNA and RNA purification, PCR and RT-PCR, cloning, in vitro transcription, and microbial genomics.
Epicentre's products are used worldwide in academic, commercial, and government laboratories in diverse applications, including basic research, drug discovery, cancer research, infectious disease research, microbiology, and personalized medicine.
On January 10, 2011 Epicentre was acquired by Illumina, Inc. The company continues to operate as a wholly owned subsidiary of Illumina from its headquarters in Madison, Wisconsin.
On January 15, 2014 Epicentre obtained certification to ISO 13485:2003 from the British Standards Institute (BSI). Compliance to this Quality System Standard drives Epicentre to focus on continual improvements and to provide the highest quality products and services to our customers. The Quality Certificate and information on other Illumina sites around the world are available.